A curing agent or a curing accelerator which is easy to synthesize and may cure an epoxy resin and the like, or may accelerate the curing is provided. A curing agent or a curing accelerator according to some embodiments of the present invention has a highly-coordinated silicon structure.

Analgesic compounds for treatment of pain or fever that include a bicyclopentane moiety linked to an amine, combinations of the compounds with opioid analgesic drugs, and methods for treating pain or fever by administering a compound described herein.

Analgesic compounds for treatment of pain or fever that include a bicyclopentane moiety linked to an amine, combinations of the compounds with opioid analgesic drugs, and methods for treating pain or fever by administering a compound described herein.

A phenalene-1-one compound, a photosensitizer composition including the phenalene-1-one compound, an article including the phenalene-1-one compound and/or photosensitizer composition and the use thereof.

A phenalene-1-one compound, a photosensitizer composition including the phenalene-1-one compound, an article including the phenalene-1-one compound and/or photosensitizer composition and the use thereof.

A reactive antibacterial compound is represented by formula (I) or (II): ##STR00001##
wherein R.sub.1 represents OCN-L-NHCOOR, OCN-L-NHCONHR, OCN-L-NHCOSR, OCN-L-COOR, or OCN-L-COONHR. G1 represents OCN-M-NHCOOG, OCN-M-NHCONHG, OCN-M-NHCOSG, OCN-M-COOG, or OCN-M-COONHG. L, M, R and G independently for each occurrence represent divalent alkyl and cycloalkyl having from 1 to 18 carbon atoms, optionally substituted by up to 18 heteroatoms. R.sub.4 and G.sub.4 independently for each occurrence represent a divalent alkyl and cycloalkyl having from 1 to 18 carbon atoms, optionally substituted by up to 18 heteroatoms. G.sub.2 and G.sub.3 independently for each occurrence represent H, F, Cl, Br, I, OCH3, OCH2CH3, OPr, CN, SCN, NO, NO2, a monovalent unsubstituted or substituted alkyl, cycloalkyl, or aryl having from 1 to 7 carbon atoms. Z and X independently for each occurrence represent COO, SO3, or OPO2OR.sub.5. R.sub.5 represents a monovalent unsubstituted or substituted alkyl, cycloalkyl, or aryl having from 1 to 6 carbon atoms.

A reactive antibacterial compound is represented by formula (I) or (II): ##STR00001##
wherein R.sub.1 represents OCN-L-NHCOOR, OCN-L-NHCONHR, OCN-L-NHCOSR, OCN-L-COOR, or OCN-L-COONHR. G1 represents OCN-M-NHCOOG, OCN-M-NHCONHG, OCN-M-NHCOSG, OCN-M-COOG, or OCN-M-COONHG. L, M, R and G independently for each occurrence represent divalent alkyl and cycloalkyl having from 1 to 18 carbon atoms, optionally substituted by up to 18 heteroatoms. R.sub.4 and G.sub.4 independently for each occurrence represent a divalent alkyl and cycloalkyl having from 1 to 18 carbon atoms, optionally substituted by up to 18 heteroatoms. G.sub.2 and G.sub.3 independently for each occurrence represent H, F, Cl, Br, I, OCH3, OCH2CH3, OPr, CN, SCN, NO, NO2, a monovalent unsubstituted or substituted alkyl, cycloalkyl, or aryl having from 1 to 7 carbon atoms. Z and X independently for each occurrence represent COO, SO3, or OPO2OR.sub.5. R.sub.5 represents a monovalent unsubstituted or substituted alkyl, cycloalkyl, or aryl having from 1 to 6 carbon atoms.

Technologies relating to increasing hydraulic fracturing efficiencies in subterranean zones by degrading organic matter, such as kerogen, are described. A method for treating kerogen in a subterranean zone includes placing a composition in the subterranean zone, and the composition includes an oxidizer including sodium bromate and an additive including a tetrasubstituted ammonium salt.

Technologies relating to increasing hydraulic fracturing efficiencies in subterranean zones by degrading organic matter, such as kerogen, are described. A method for treating kerogen in a subterranean zone includes placing a composition in the subterranean zone, and the composition includes an oxidizer including sodium bromate and an additive including a tetrasubstituted ammonium salt.

An aqueous electrolyte composition suitable for a lithium secondary battery is provided. The aqueous electrolyte composition contains water; lithium bis(fluorosulfonyl) imide (LiFSI); and an ionic liquid comprising an organic cation and a bis(fluorosulfonyl) imide anion (FSI); wherein the ionic liquid is a liquid at 20 C. A lithium secondary battery containing the aqueous electrolyte and a vehicle at least partially powered by the battery are also provided.